Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2018-01-05 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
关于召开2018年第一次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the 2018 first extraordinary general meeting of shareholders for a company, detailing the meeting time, voting procedures, proposal to be voted on, and proxy authorization forms. It does not contain financial statements or results but is an announcement related to a shareholders' meeting. The content fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document is not a full annual report, earnings release, or other financial report, but a meeting notice and related procedural information.
2018-01-05 Chinese
关于重大资产重组停牌进展公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the progress of a major asset restructuring and the continuation of stock suspension due to this restructuring. It references multiple previous announcements about the suspension and progress updates. The document does not contain financial statements or detailed financial data but rather updates on the status of the asset restructuring and stock suspension. It is a regulatory announcement about the ongoing process rather than a full report or financial disclosure. Therefore, it fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2018-01-04 Chinese
关于投资设立全资子公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's investment to establish a wholly-owned subsidiary. It includes details about the investment amount, board approval, company information, and the purpose and risks of the investment. There are no financial statements or detailed financial performance data. The document is a formal announcement of a capital investment decision, not a financial report or earnings release. It fits the category of Capital/Financing Update (CAP) as it relates to company fundraising or capital structure changes through investment in a subsidiary.
2018-01-03 Chinese
七届董事会2018年第一次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board meeting resolution by the company 中粮生物化学（安徽）股份有限公司. It details the convening of the seventh board's first interim meeting in 2018, the attendance and voting results, and the approval of an investment to establish a wholly-owned subsidiary. There is no detailed financial data or comprehensive report content, but rather a summary of board decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document length is short and focused on board resolutions, not a full report or financial statement.
2018-01-03 Chinese
关于重大资产重组停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a major asset restructuring and the continuation of stock suspension (停牌) due to this restructuring. It references multiple previous announcements about the suspension and the ongoing process of the asset reorganization. The document does not contain financial statements or detailed financial data but rather updates on the status and regulatory compliance related to the restructuring and stock suspension. This fits the category of a Capital/Financing Update (CAP) as it relates to significant corporate financing and restructuring activities, not a full report or audit. The document length is short (1725 characters), and it is not a report publication announcement or a certification. Therefore, the best classification is CAP with high confidence.
2017-12-28 Chinese
独立董事关于对相关事项的事前确认函
Regulatory Filings Classification · 95% confidence The document is a confirmation letter from independent directors regarding the pre-approval of increased related party transactions for the year 2017. It includes opinions on compliance with stock exchange rules and company bylaws, and signatures of independent directors. The document is short (453 characters) and does not contain financial statements or detailed financial data. It is a regulatory or compliance-related letter rather than a full report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS) as it is a formal attestation related to corporate governance and compliance.
2017-12-21 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.